Research Topics
Genomes and GenesSpecies | Thomas ForstSummaryAffiliation: Institute for Clinical Research and Development Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitusThomas Forst
Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 6:163-8. 2012..The aim of this study was to investigate early morphological and functional pathology in the retinal micro-circulation in patients with insulin resistance and/or type 2 diabetes mellitus (T2DM)...
Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: theMarkolf Hanefeld
GWT TUD mbH, Fiedlerstr 34, 01307 Dresden, Germany
Cardiovasc Diabetol 10:65. 2011..We analyzed specific effects of an add-on therapy with pioglitazone compared to metformin and their combination in patients with basal insulin treatment on biomarkers of CV risk...
Effects of C-peptide on microvascular blood flow and blood hemorheologyT Forst
Institute for Clinical Research and Development, Mainz, Germany
Exp Diabesity Res 5:51-64. 2004..In conclusion, C-peptide improves microvascular function and blood flow in type 1 diabetic patients by interfering with vascular and rheological components of microvascular blood flow...
IRIS II study: the IRIS II score--assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetesT Forst
Institute for Clinical Research and Development, Mainz, Germany
Diabet Med 21:1149-53. 2004..The aim of our study was to compute a new algorithm for estimating insulin resistance in a routine clinical setting...
Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patientsT Forst
Institute for Clinical Research and Development, Mainz, Germany
Horm Metab Res 41:123-31. 2009..The coexistence of insulin resistance with functional beta cell failure results in loss of blood glucose control especially after a meal and increases the cardiovascular risk of these patients far beyond the increased glucose levels...
Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial beta-cell protection in individuals with type 2 diabetesT Forst
Institute for Clinical Research and Development, Clinical Department, Mainz, Germany
Diabetes Obes Metab 12:437-41. 2010..This open-label, parallel-group, two-arm, pilot study compared the beta-cell protective effect of adding insulin glargine (GLA) vs. NPH insulin to ongoing metformin...
Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetesThomas Forst
Institute for Clinical Research and Development, Parcusstrasse 8, Mainz D 55116, Germany
J Diabetes Complications 19:128-32. 2005..0 (19.0-49.3) vs. 20.9 (9.7-26.1) AU, P=.0001]. Postprandial microvascular blood flow is disturbed in patients with Type 1 diabetes. Improvement of postprandial metabolic control was found to improve postprandial microvascular function...
[Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others]T Forst
Institut für klinische Forschung und Entwicklung, Mainz, Mainz, Germany
Dtsch Med Wochenschr 131:S268-73. 2006..Measurement of inflammation, by high sensitive CRP might add further information about the cardiovascular risk of a patient with type 2 diabetes...
Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetesT Forst
Institute for Clinical Research and Development, Mainz, Germany
Horm Metab Res 37:521-7. 2005..37; p < 0.0001). Measurement of adiponectin and intact proinsulin enables characterization of the metabolic situation and an estimation of atherosclerotic risk in patients with type 2 diabetes...
Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2Thomas Forst
Institute for Clinical Research and Development, Mainz, Germany
Microcirculation 12:543-50. 2005..The study was performed to investigate the effect of improving metabolic control with pioglitazone in comparison to glimepiride on microvascular function in patients with diabetes mellitus type 2...
Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patientsA Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Horm Metab Res 41:202-6. 2009..The regulation of RBP4 expression and secretion occurs through biochemical pathways independent from those influenced by pioglitazone or simvastatin...
Impact of environmental temperature on skin thickness and microvascular blood flow in subjects with and without diabetesT Forst
Institute for Clinical Research and Development and Department of Endocrinology and Diabetes, Johannes Gutenberg University, Mainz, Germany
Diabetes Technol Ther 8:94-101. 2006..Our study was performed to investigate the effect of changes in ambient temperature on skin thickness and microvascular skin blood flow in subjects with and without diabetes at the lower forearm...
Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen deviceThomas Forst
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 11:87-92. 2009....
Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris deviceT Forst
Institute for Clinical Research and Development ikfe GmbH, Mainz, Germany
Diabetes Nutr Metab 17:163-8. 2004..In conclusion, our study indicates that the new TENS device "Salutaris" is a convenient, non-pharmacological option for primary or adjuvant treatment of painful diabetic neuropathy...
Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitusThomas Forst
Institute for Clinical Research and Development, University of Mainz, Germany
Clin Sci (Lond) 119:345-51. 2010..47; P<0.05). This is the first study showing an improvement in EI during treatment with PIO, which was associated with an increase in adiponectin and a decrease in intact proinsulin levels, but independent of glycaemic control...
Linagliptin, a dipeptidyl peptidase-4 inhibitor with a unique pharmacological profile, and efficacy in a broad range of patients with type 2 diabetesThomas Forst
Institute for Clinical Research and Development, Mainz, Germany
Expert Opin Pharmacother 13:101-10. 2012..It has a unique pharmacological profile within its class and, unlike other DPP-4 inhibitors, linagliptin does not require dose adjustment in patients with renal impairment...
Role of C-Peptide in the regulation of microvascular blood flowT Forst
Medical Department, Institute for Clinical Research and Development, 55116 Mainz, Germany
Exp Diabetes Res 2008:176245. 2008....
Metabolic effects of mealtime insulin lispro in comparison to glibenclamide in early type 2 diabetesT Forst
Institute for Clinical Research and Development, Mainz, Germany
Exp Clin Endocrinol Diabetes 111:97-103. 2003..In addition, use of LP was associated with a decrease in fasting C-peptide and proinsulin levels, suggesting a potential down regulation of endogenous insulin production and improved proinsulin processing efficiency...
Review of approved pioglitazone combinations for type 2 diabetesThomas Forst
IKFE Institute for Clinical Research and Development, Parcusstr 8, D 5116 Mainz, Germany
Expert Opin Pharmacother 12:1571-84. 2011..The treating of T2DM patients by addressing not only glucose control, but also the underlying pathophysiological etiology might help to improve patient prognosis in the long run, especially with regard to the vascular complications...
Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetesThomas Forst
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Care 33:116-20. 2010..This study compared the effect of VIAject with human regular insulin and insulin lispro on postprandial oxidative stress and endothelial function in patients with type 2 diabetes...
Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery diseaseT Forst
Institute for Clinical Research and Development, Parcusstrasse 8, D 55116 Mainz, Germany
Atherosclerosis 197:311-7. 2008..No changes in these parameters could be observed during placebo treatment. Even before effects on glucose metabolism could be obtained, pioglitazone exerts immediate effects on plasma markers of plaque vulnerability and inflammation...
[The diagnosis of an autonomic dysfunction of the lower limb as a major aspect of the neurological investigation and risk assessment of a diabetic foot syndrome]Th Forst
Institut für klinische Forschung und Entwicklung, Mainz
MMW Fortschr Med 146:35-8. 2004..A purposeful assessment of risk and prevention of neurotrophic damage in the lower limb is possible only on the basis of a rigorous differential diagnostic work-up of the diabetic polyneuropathy...
Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular riskThomas Forst
Medical Director, Institute for Clinical Research and Development, Mainz, Germany
Diab Vasc Dis Res 5:298-303. 2008..05 respectively). Atorvastatin significantly improved IMT and vascular elasticity. Co-administration of pioglitazone provided additional effects on endothelial function, lipid profile and laboratory markers of inflammation...
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic painThomas Forst
Institute for Clinical Research and Development and Department of Endocrinology, University of Mainz, Mainz, Germany
Br J Clin Pharmacol 64:75-82. 2007..The purpose of the current study was to establish the safety and maximal tolerated dose of CNS 5161 HCl...
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT StudyThomas Forst
Institute for Clinical Research and Development, Medical Department, D 55116 Mainz, Germany
Metabolism 56:491-6. 2007..05) during PIO/SIM treatment. Lipid parameters improved during SIM treatment but not during PIO treatment. Combined treatment with PIO/SIM was superior in improving overall cardiovascular risk profile than every single drug...
Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot studyPetra B Musholt
Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 3:1442-50. 2009..The aim of our study was to examine the efficacy of short-term intravenous insulin intervention followed by oral pioglitazone/metformin therapy to prevent patients from continuous insulin application...
Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial stateClothilde Hohberg
Institute for Clinical Research and Development, Parcusstrasse 8, D 55116 Mainz, Germany
Diabetes Care 31:1021-5. 2008..To investigate the effect of insulin glulisine on postprandial microvascular blood flow in type 2 diabetes...
The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix studyThomas Schondorf
Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:426-32. 2011..This study investigates the impact of a pioglitazone plus metformin therapy on biomarkers of inflammation and platelet activation in comparison to a treatment with glimepiride plus metformin...
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitusThomas Schondorf
Institute for Clinical Research and Development, Mainz, Germany
Gynecol Endocrinol 23:356-60. 2007..Therefore, the present study investigated the correlation of relaxin expression with fibrinogen levels in diabetes patients undergoing oral antidiabetic treatment...
Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepirideAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Metabolism 55:20-5. 2006..In conclusion, our short-term investigation of rosiglitazone action provides further experimental support for the rationale of combining rosiglitazone with sulfonylurea drugs in patients with type 2 diabetes...
PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemiaAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 13:637-43. 2011..The aim of our study was to investigate the effect of a fixed pioglitazone?+?metformin (PM) combination (vs. glimepiride?+?metformin [GM]) on diabetic dyslipidemia...
Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim studyAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 12:599-604. 2010....
Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat studyAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Clin Lab 55:275-81. 2009..We evaluated the plausibility of results derived from a new ELISA (Immundiagnostik, Bensheim, Germany) in comparison to a different ELISA test (Mercodia, Uppsala, Sweden)...
IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistanceMatthias R Langenfeld
IKFE Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 6:836-43. 2004....
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer studyAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Parcusstrasse 8, D 55116 Mainz, Germany
J Am Coll Cardiol 45:1925-31. 2005..This study was performed to assess whether the anti-inflammatory and antiatherogenic effects of pioglitazone suggested by animal experiments are reproducible in man and independent from improvements in metabolic control...
Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace studyAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:989-98. 2011..This study investigated the effects of pioglitazone (PIO), ramipril (RAM), or their combination (PIRA) on low-grade inflammation in nondiabetic hypertensive patients with increased cardiovascular risk...
Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitusThomas Schondorf
Institute of Clinical Research and Development, Mainz, Germany
Clin Lab 53:193-8. 2007..In women, other pathways may superimpose this effect. In conclusion, our study supports the hypothesis of different regulating pathways and effects of relaxin in men and women also in patients with type 2 diabetes...
Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effectsAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Parcusstr 8 D 55116 Mainz, Germany
Expert Rev Cardiovasc Ther 4:445-59. 2006..These results underline the value of pioglitazone for managing the increased cardiovascular risk of patients with a metabolic syndrome or Type 2 diabetes mellitus...
Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitusAndreas Pfutzner
Institute for Clinical Research and Development, IKFE GmbH, Parcusstrasse 8, 55116 Mainz, Germany
Clin Chem Lab Med 44:556-60. 2006..Type 2 diabetes mellitus is associated with increased cardiovascular risk. One laboratory marker for cardiovascular risk assessment is high-sensitivity C-reactive protein (hsCRP)...
Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetesAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Care 27:682-7. 2004..This investigation explored the predictive value of intact proinsulin as an insulin resistance marker...
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditionsThomas Schondorf
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 11:379-83. 2009....
The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitusAndreas Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 8:375-84. 2006..Supplementary insulin therapy provides assistance to meal-time insulin secretion in patients with type 2 diabetes and may have protective effects on beta-cell function...
Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortalityAndreas Pfutzner
Institut für Klinische Forschung und Entwicklung IKFE, Institute for Clinical Research and Development, Parcusstr 8, D 55116 Mainz, Germany
Expert Opin Pharmacother 7:463-76. 2006..Because of its additional microvascular and macrovascular effects, pioglitazone is an attractive and effective treatment option for the management of Type 2 diabetes mellitus...
Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combinationAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Vasc Health Risk Manag 3:211-20. 2007..The purpose of this review is to evaluate the clinical data that have been published on this combination, appearing to represent a convenient way to obtain therapeutic targets in patients with type 2 diabetes mellitus...
Evaluation of CGMS during rapid blood glucose changes in patients with type 1 diabetesBirgit Wilhelm
Institute for Clinical Research and Development, Johannes Gutenberg University, Mainz, Germany
Diabetes Technol Ther 8:146-55. 2006..CONCLUSIONS: Continuous glucose measurements using CGMS provide reliable glucose measurements even in the case of dynamic blood glucose changes...
High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneAndreas Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 4:706-16. 2010....
Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistanceAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Clin Lab 50:567-73. 2004..Both assays can thus be used to assess beta-cell function, to facilitate the selection of the most promising therapy, and may also serve to monitor treatment success in the further course of the disease...
Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3Volkmar Schmid
IKFE CRO, Mainz, Germany
J Diabetes Sci Technol 4:976-82. 2010....
Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effectsAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Expert Opin Pharmacother 8:1985-98. 2007..They underline the value of this drug when used alone or in combination with other antidiabetic drugs for a successful management of Type 2 diabetes mellitus...
Elevated peripheral visfatin levels in narcoleptic patientsNorbert Dahmen
Department of Psychiatry, University of Mainz, Mainz, Germany
PLoS ONE 3:e2980. 2008..Visfatin is a recently described proinflammatory adipokine. It is identical to the immune modulating pre-B-cell colony enhancing factor (PBEF). Our study examines the hypothesis that visfatin levels are altered in narcoleptic patients...
Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazoneAndreas Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:784-93. 2011....
Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistanceAndreas Pfutzner
Institute of Clinical Research and Development, IKFE GmbH, Mainz, Germany
Clin Lab 49:571-6. 2003..It may, however, be concluded from this study that at least in cross-sectional epidemiological investigations, fasting human resistin concentrations are not significantly correlating with any clinical measure for insulin resistance...
Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid)Andreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Clin Lab 49:227-32. 2003..In general, the new LIAISON chemiluminescence assay compared favorably with the RIA and comparative chemiluminescence test and offers an attractive alternative for C-peptide analysis...
A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitusAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Mainz, Germany
Clin Lab 54:485-90. 2008....
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA studyThomas Schondorf
Institute for Clinical Research and Development, Mainz, Germany
Diab Vasc Dis Res 7:145-50. 2010..Patients with diabetes mellitus and IGT have a high risk for cardiovascular events. It is tempting to speculate that these patients are often first seen by cardiologists...
Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoringAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 6:435-41. 2004..Well-educated patients might be the best candidates for first using the device for continuous glucose monitoring. They may especially benefit from the trend indication and the hypoglycemia/hyperglycemia threshold and alarm functions...
Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the testsMichael Safinowski
Institute for Clinical Research and Development, Mainz, Germany
Clin Chem Lab Med 47:483-8. 2009..The peroxynitrite concentrations can be indirectly monitored by the detection of nitrotyrosine residues in proteins, reflecting the extent of damage caused by oxidative stress...
Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?Marco Klemm
PharmGenomics GmbH, Mainz, Germany
Clin Lab 56:473-80. 2010....
Evaluation of SET--a new device for the measurement of pain perception in comparison to standard measures of diabetic neuropathyMai Nguyen
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 6:601-6. 2004..82; vibration = 0.61; temperature = 0.42; light touch = 0.11). CONCLUSIONS: Measurement of pain perception threshold using the SET device is an easy and reliable method for identifying patients with impaired small nerve fiber function...
Evaluation of dexterity in insulin-treated patients with type 1 and type 2 diabetes mellitusJulia Pfützner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:158-65. 2011..Dexterity skills may play an important role in the performance efficacy of these procedures...
Pulmonary insulin delivery by means of the Technosphere drug carrier mechanismAndreas Pfutzner
Institute for Clinical Research and Development, Parcusstr 8, D 55116 Mainz, Germany
Expert Opin Drug Deliv 2:1097-106. 2005..Provided a reliable long-term safety profile, TI may become a suitable alternative to subcutaneous injection for prandial insulin delivery. TI offers the possibility of new treatment regimens, especially in patients with Type 2 diabetes...
Investigation of insulin resistance in narcoleptic patients: dependent or independent of body mass index?Alice Engel
Department of Psychiatry, University of Mainz, Germany
Neuropsychiatr Dis Treat 7:351-6. 2011..Narcoleptic patients have been reported to suffer from an excess morbidity of Type 2 diabetes, even after correction for their often elevated body mass index...
Laboratory evaluation of a new lateral-flow-based point-of-care rapid test for assessment of chronic systemic inflammationRenate Siebenhaar
IKFE Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 4:717-22. 2010..It may therefore be suitable for a fast and convenient screening, which, after laboratory test confirmation, may help to identify patients with elevated risk of macrovascular disease...
Downregulation of the proinflammatory state of circulating mononuclear cells by short-term treatment with pioglitazone in patients with type 2 diabetes mellitus and coronary artery diseaseAndreas Pfutzner
IKFE Institute for Clinical Research and Development, Research Laboratory, 55116 Mainz, Germany
PPAR Res 2011:647017. 2011....
Analysis of the environmental impact of insulin infusion sets based on loss of resources with wasteAndreas Pfutzner
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 5:843-7. 2011..The loss or resources with regular CSII is considerably lower than the loss or resources induced by patch pumps...
Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitusAndreas Pfutzner
Institute for Clinical Research and Development, Mainz, Germany
Diabetes Technol Ther 6:405-12. 2004..Assessment of beta-cell function by determination of intact proinsulin may facilitate the selection of the most promising therapy and may also serve to monitor treatment success in the further course of the disease...
Assessment of the mixing efficiency of neutral protamine Hagedorn cartridgesPia Kaiser
IKFE, Institute for Clinical Research and Development, Mainz, Germany
J Diabetes Sci Technol 4:652-7. 2010..All other cartridges with fewer bullets were shown to deliver potentially harmful doses if used for treatment when the mixing procedure was less frequent than demanded in the instructions for use...
Peripheral leptin levels in narcoleptic patientsNorbert Dahmen
Department of Psychiatry, University of Mainz, Mainz, Germany
Diabetes Technol Ther 9:348-53. 2007..Two studies have reported decreased leptin levels, whereas a larger, recent study failed to detect differences between patients and controls...
IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study designAndreas Pfutzner
University of Applied Sciences, Rheinbach, Germany
Diabetes Technol Ther 7:478-86. 2005..The cross-sectional IRIS-II study tried to assess the prevalence of insulin resistance and macrovascular disease in orally treated patients with Type 2 diabetes...
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitusAndreas Pfutzner
University of Applied Sciences, Rheinbach, Germany
Diabetes Technol Ther 8:28-36. 2006..Positive results in these trials will further strengthen the value and acceptance of hsCRP, which is recommended as a predictive laboratory marker for cardiovascular disease risk also in patients with diabetes mellitus...
Cross-sectional investigation on the accuracy of alternate site glucose testing using the Soft-Sense glucose meterAndreas Pfutzner
Institut für klinische Forschung und Entwicklung, Mainze
Swiss Med Wkly 132:351-7. 2002....
Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulinAndreas Pfutzner
IKFE, Institute of Clinical Research and Development, Mainz, Germany
Clin Chem Lab Med 41:1234-8. 2003..Both CLIAs could be performed much faster (4 hours) than the RIA method (75 hours/ 4 days). In conclusion, the CLIA methods show improved qualitative outcomes, higher specificity and several technical advantages over the RIA method...
Investigation on the accuracy of the blood glucose monitoring device Prestige IQM Larbig
Institut für Klinische Forschung und Entwicklung IKFE GmbH, Mainz, Germany
Diabetes Nutr Metab 16:257-61. 2003..In conclusion, Prestige IQ showed excellent performance with clinically acceptable accuracy and reliability as compared to both the laboratory reference and the four commercially available self-monitoring blood glucose systems...
Stimulation of endothelial nitric oxide synthase by proinsulin C-peptideThomas Wallerath
Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany
Nitric Oxide 9:95-102. 2003..We suggest that this effect may contribute to the increase in skin and muscle blood flow previously demonstrated in human in vivo...
Effect of C-peptide on glucose metabolism in patients with type 1 diabetesThomas Forst
Diabetes Care 25:1096-7. 2002
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT StudyMarkolf Hanefeld
GWT, Center for Clinical Studies, Dresden, Germany
J Am Coll Cardiol 49:290-7. 2007....
Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapyChristof Kazda
Lilly Deutschland GmbH, Bad Homburg, Germany
J Diabetes Complications 20:145-52. 2006..To compare the effects of prandial insulin therapy focusing on postprandial glucose control vs. basal insulin therapy focusing on fasting glucose control in patients with type 2 diabetes...
Development and validation of a new measure to evaluate psychological resistance to insulin treatmentFrank Petrak
Department for Psychosomatic Medicine and Psychotherapy, LWL Clinic Dortmund Ruhr University of Bochum, Dortmund, Germany
Diabetes Care 30:2199-204. 2007..To develop a psychometric questionnaire to measure psychological barriers to insulin treatment in patients with type 2 diabetes...
The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditionsEfstrathios Karagiannis
Takeda Pharma, Aachen, Germany
Diabetes Technol Ther 10:206-12. 2008..This observational trial was performed to evaluate the effects of pioglitazone on hsCRP values in a large population under daily life conditions...
C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patientsThomas Hach
Department of Internal Medicine, University of Mainz, 55101 Mainz, Germany thomas
Exp Diabetes Res 2008:730594. 2008..This study aimed to investigate the influence of C-peptide and fragments thereof on erythrocyte deformability and to elucidate the relevant signal transduction pathway...
Short communication: high prevalence of the cytochrome P450 2C8*2 mutation in Northern GhanaSusanne Röwer
Institute of Tropical Medicine, Charite University Medicine Berlin, Berlin, Germany
Trop Med Int Health 10:1271-3. 2005..We did not detect CYP2C8*3 and CYP2C8*4, but CYP2C8*2 showed an allele frequency of 0.1675. AQ metabolism in patients with CYP2C8*2 may be impaired, and with an increase of AQ based treatment the risk of severe adverse events may mount...
New tricks by an old dogThomas Forst
Exp Diabetes Res 2008:384219. 2008
